Immunotherapy-based strategies for gastrointestinal carcinomas (GIC) have been exploited so far, but these approaches have to face strong mechanisms of immune escape induced by tumours. We previously demonstrated that sub-therapeutic doses of an adenovirus expressing IL-12 genes (AdIL-12) mediated a potent antitumour effect against subcutaneous (s.c.) colorectal carcinomas (CRC) in mice pre-treated with low doses of cyclophosphamide (Cy). In our study we used this combination to assess its impact on the immunosuppressive microenvironment. In s.c. CRC model we demonstrated that non-responder mice failed to decrease Tregs in tumour, spleen and peripheral blood. Reconstitution of Tregs into tumour-bearing mice treated with combined therapy abo...
The use of gene therapy to enhance antitumor immunity has emerged as a promising procedure to fight ...
Stimulation of the antitumor immune response by dendritic cells (DC) is critically dependent on thei...
Background: Active-specific immunotherapy used as an adjuvant therapeutic strategy is rather unexplo...
The use of conventional cytotoxic agents at metronomic schedules, alone or in combination with targe...
PURPOSE: To evaluate the feasibility and safety of intratumoral injection of autologous dendritic...
Intralesional administration of cultured dendritic cells (DCs) engineered to produce IL-12 by in vit...
Combined injections into experimental tumor nodules of adenovirus encoding IL-12 and certain chemoki...
PURPOSE: Systemic treatment with an anti-ICAM-2 monoclonal antibody (mAb; EOL4G8) eradicates certai...
Interleukin-12 (IL-12) has been shown to possess potent immunoregulatory and antitumoral effects. We...
Colorectal cancer (CRC) represents the third most common malignancy and the second leading cause of ...
Tumors infected with a recombinant defective adenovirus expressing interleukin 12 (IL-12) undergo re...
Interleukin-12 immune stimulation lacks efficacy in established solid tumor models. Disruption of tu...
Advances in immunology have increased the possibility to develop therapeutic cancer vaccines (TCV), ...
The liver expressed chemokine CCL16/LEC exerts chemotactic activity on human monocytes and lymphocyt...
BACKGROUND: Gene therapy is a novel approach for the treatment of cancers, and tumours disseminated ...
The use of gene therapy to enhance antitumor immunity has emerged as a promising procedure to fight ...
Stimulation of the antitumor immune response by dendritic cells (DC) is critically dependent on thei...
Background: Active-specific immunotherapy used as an adjuvant therapeutic strategy is rather unexplo...
The use of conventional cytotoxic agents at metronomic schedules, alone or in combination with targe...
PURPOSE: To evaluate the feasibility and safety of intratumoral injection of autologous dendritic...
Intralesional administration of cultured dendritic cells (DCs) engineered to produce IL-12 by in vit...
Combined injections into experimental tumor nodules of adenovirus encoding IL-12 and certain chemoki...
PURPOSE: Systemic treatment with an anti-ICAM-2 monoclonal antibody (mAb; EOL4G8) eradicates certai...
Interleukin-12 (IL-12) has been shown to possess potent immunoregulatory and antitumoral effects. We...
Colorectal cancer (CRC) represents the third most common malignancy and the second leading cause of ...
Tumors infected with a recombinant defective adenovirus expressing interleukin 12 (IL-12) undergo re...
Interleukin-12 immune stimulation lacks efficacy in established solid tumor models. Disruption of tu...
Advances in immunology have increased the possibility to develop therapeutic cancer vaccines (TCV), ...
The liver expressed chemokine CCL16/LEC exerts chemotactic activity on human monocytes and lymphocyt...
BACKGROUND: Gene therapy is a novel approach for the treatment of cancers, and tumours disseminated ...
The use of gene therapy to enhance antitumor immunity has emerged as a promising procedure to fight ...
Stimulation of the antitumor immune response by dendritic cells (DC) is critically dependent on thei...
Background: Active-specific immunotherapy used as an adjuvant therapeutic strategy is rather unexplo...